CD4 and thymic carcinoma: Hence, the increased populations of single-positive CD4 and CD8 T-cells, encountered in B2/B3 thymomas and thymic carcinomas, predispose to higher sensitivity to PD-L1 inhibition and render these TET subtypes more vulnerable to elimination by ICIs.